Funding for this research was provided by:
National Natural Science Foundation of China (81801991, 81873962, 91842309, 91542207)
Chinese foundation for hepatitis prevention and control-TianQing liver disease research fund subject (TQGB20200164)
The National Science and Technology Major Project of China (2018ZX10305409-001-005, 2017ZX10103009-001)
Received: 30 July 2020
Accepted: 21 January 2021
First Online: 23 February 2021
: The authors declare no competing interests.